Motoh Iwasa, Ryosuke Sugimoto, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Naoto Fujiwara, Hideaki Tanaka, Yoshinao Kobayashi, Jiro Ikoma, Masahiko Kaito, et al. Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumption. European journal of gastroenterology & hepatology. 2024. 36. 6. 793-801
Yoshinao Kobayashi, Akiko Eguchi, Koshi Imami, Mina Tempaku, Kiyora Izuoka, Takafumi Takase, Keigo Kainuma, Mizuho Nagao, Noriko Furuta, Motoh Iwasa, et al. Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity. Journal of molecular medicine (Berlin, Germany). 2023
Ryuta Shigefuku, Motoh Iwasa, Akiko Eguchi, Mina Tempaku, Yasuyuki Tamai, Naoto Fujiwara, Ryosuke Sugimoto, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, et al. Serum Zinc-α2-glycoprotein Levels are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease. Internal medicine (Tokyo, Japan). 2023
Ryosuke Sugimoto, Motoh Iwasa, Akiko Eguchi, Yasuyuki Tamai, Ryuta Shigefuku, Naoto Fujiwara, Hideaki Tanaka, Yoshinao Kobayashi, Jiro Ikoma, Masahiko Kaito, et al. Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients. Frontiers in medicine. 2023. 10. 1073025-1073025
Yasuyuki Tamai, Motoh Iwasa, Akiko Eguchi, Ryuta Shigefuku, Ryosuke Sugimoto, Hideaki Tanaka, Yoshinao Kobayashi, Shugo Mizuno, Hayato Nakagawa. The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment. European journal of gastroenterology & hepatology. 2022. 34. 12. 1269-1276